AQR Capital Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.89M Sell
274,932
-139,810
-34% -$1.75M ﹤0.01% 2111
2025
Q4
$5.36M Buy
414,742
+217,919
+111% +$2.8M ﹤0.01% 1534
2025
Q3
$2.54M Buy
196,823
+162,826
+479% +$2.18M ﹤0.01% 1839
2025
Q2
$605K Buy
33,997
+5,269
+18% +$91.8K ﹤0.01% 2507
2025
Q1
$512K Buy
28,728
+10,394
+57% +$236K ﹤0.01% 2422
2024
Q4
$546K Buy
18,334
+1,820
+11% +$38.5K ﹤0.01% 2207
2024
Q3
$257K Sell
16,514
-414,931
-96% -$7.52M ﹤0.01% 2465
2024
Q2
$7.39M Buy
431,445
+302,351
+234% +$5.32M 0.01% 857
2024
Q1
$1.99M Sell
129,094
-31,247
-19% -$460K ﹤0.01% 1415
2023
Q4
$2.39M Buy
160,341
+130,794
+443% +$1.75M ﹤0.01% 1261
2023
Q3
$477K Buy
+29,547
New +$852K ﹤0.01% 1865
2021
Q4
Sell
-4,707
Closed -$546K 2254
2021
Q3
$546K Sell
4,707
-12,973
-73% -$1.96M ﹤0.01% 1832
2021
Q2
$3.92M Sell
17,680
-6,669
-27% -$1.3M 0.01% 914
2021
Q1
$3.18M Buy
24,349
+13,622
+127% +$2.15M 0.01% 959
2020
Q4
$1.86M Buy
+10,727
New +$1.47M ﹤0.01% 1202
2020
Q3
Sell
-82,003
Closed -$4.86M 2246
2020
Q2
$4.86M Buy
82,003
+8,252
+11% +$543K 0.01% 796
2020
Q1
$4.97M Buy
73,751
+35,686
+94% +$2.82M 0.01% 778
2019
Q4
$3.21M Sell
38,065
-2,073
-5% -$167K ﹤0.01% 1096
2019
Q3
$3M Buy
40,138
+8,239
+26% +$659K ﹤0.01% 1137
2019
Q2
$2.02M Sell
31,899
-6,658
-17% -$337K ﹤0.01% 1259
2019
Q1
$1.86M Sell
38,557
-4,261
-10% -$205K ﹤0.01% 1344
2018
Q4
$1.43M Sell
42,818
-153,893
-78% -$5.63M ﹤0.01% 1373
2018
Q3
$10.3M Sell
196,711
-32,399
-14% -$1.29M 0.01% 772
2018
Q2
$7.17M Buy
229,110
+52,649
+30% +$1.46M 0.01% 896
2018
Q1
$3.85M Buy
176,461
+10,665
+6% +$229K ﹤0.01% 1099
2017
Q4
$3.35M Buy
165,796
+140,292
+550% +$2.7M ﹤0.01% 1173
2017
Q3
$506K Buy
+25,504
New +$501K ﹤0.01% 1931

Other funds holding NVCR